TrialClinical pharmacology and therapeutics2017

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.

R M Savic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.